BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salvaterra E, Campo I. Pulmonary alveolar proteinosis: from classification to therapy. Breathe (Sheff) 2020;16:200018. [PMID: 32684997 DOI: 10.1183/20734735.0018-2020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu H, Tian M, Bai Y, Ran X, Li L, Chen Y. CD40LG-associated X-linked Hyper-IgM Syndrome (XHIGM) with Pulmonary Alveolar Proteinosis: A Case Report.. [DOI: 10.21203/rs.3.rs-2501253/v1] [Reference Citation Analysis]
2 Lazarus HM, Pitts K, Wang T, Lee E, Buchbinder E, Dougan M, Armstrong DG, Paine R 3rd, Ragsdale CE, Boyd T, Rock EP, Gale RP. Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders. Front Immunol 2022;13:1069444. [PMID: 36685591 DOI: 10.3389/fimmu.2022.1069444] [Reference Citation Analysis]
3 Šterclová M. Pulmonary storage. Vnitr Lek 2022;68:525-31. [PMID: 36575071 DOI: 10.36290/vnl.2022.111] [Reference Citation Analysis]
4 Chevereau-choquet M, Marchand-adam S, Mankikian J, Bergemer-fouquet A, Eymieux S, Flament T. Protéinose pulmonaire secondaire chez un patient greffé. Revue des Maladies Respiratoires 2022;39:795-800. [DOI: 10.1016/j.rmr.2022.09.004] [Reference Citation Analysis]
5 Khan SNS, Stirling RG, Mclean CA, Russell PA, Hoy RF. GM‐CSF antibodies in artificial stone associated silicoproteinosis: A case report and literature review. Respirology Case Reports 2022;10. [DOI: 10.1002/rcr2.1021] [Reference Citation Analysis]
6 Fan G, Huang Y, Xue F, He B. Complete remission of pulmonary alveolar proteinosis after anti-tuberculous chemotherapy: a case report. J Int Med Res 2022;50:3000605221113785. [PMID: 35899929 DOI: 10.1177/03000605221113785] [Reference Citation Analysis]
7 Mariani F, Salvaterra E, Lettieri S, De Silvestri A, Corino A, Bosio M, Fraolini E, Piloni D, Rodi G, Corsico AG, Campo I. A mini-whole lung lavage to treat autoimmune pulmonary alveolar proteinosis (PAP). Respir Res 2022;23:60. [PMID: 35300687 DOI: 10.1186/s12931-022-01982-2] [Reference Citation Analysis]
8 Bai JW, Gu SY, Sun XL, Lu HW, Liang S, Xu JF. CYFRA21-1 is a more sensitive biomarker to assess the severity of pulmonary alveolar proteinosis. BMC Pulm Med 2022;22:2. [PMID: 34980056 DOI: 10.1186/s12890-021-01795-x] [Reference Citation Analysis]
9 Milad N, Morissette MC. Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure. Eur Respir Rev 2021;30:210077. [PMID: 34911693 DOI: 10.1183/16000617.0077-2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ataya A, Knight V, Carey BC, Lee E, Tarling EJ, Wang T. The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review. Front Immunol 2021;12:752856. [PMID: 34880857 DOI: 10.3389/fimmu.2021.752856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Retzinger AC, Retzinger GS. The Role of Surface in the Pathogenesis and Treatment of COVID-19. COVID 2021;1:465-471. [DOI: 10.3390/covid1020040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Bates D. Pulmonary alveolar proteinosis. Radiopaedia.org 2021. [DOI: 10.53347/rid-90324] [Reference Citation Analysis]
13 Beeckmans H, Bos S, Vos R. Selection Criteria for Lung Transplantation: Controversies and New Developments. Semin Respir Crit Care Med 2021;42:329-45. [PMID: 34030197 DOI: 10.1055/s-0041-1728756] [Reference Citation Analysis]
14 Amin S, Puri P, Chen SCA, Mahajan H, Neill L, Wong G. Pulmonary Alveolar Proteinosis and Scedosporium aurantiacum Lung Infection in a Kidney Transplant Recipient. Kidney Int Rep 2021;6:2232-6. [PMID: 34386675 DOI: 10.1016/j.ekir.2021.05.002] [Reference Citation Analysis]